Innovimmune Biotherapeutics
Get Full AccessDescription
- INNOVIMMUNE is a specialty Drug Discovery & Exploratory Development biotechnology company leading the development of novel first-in-class and best-in-class proprietary oral small molecule NME immunomodulatory drugs for the treatment of Autoimmune, Inflammatory and Oncologic Diseases.Follow us on Twitter: @Innovimmune
-
Headquarters:Innovimmune Biotherapeutics , New York, New York, United States
More -
Phone Number: +1 212-513-1786
-
Website: https://www.innovimmune.com
-
Employees:6
-
Revenue:$1 - 10M
-
Legal Name:Innovimmune Biotherapeutics
-
Innovimmune Biotherapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
View Employees
Frequently Asked Questions regarding Innovimmune Biotherapeutics
-
Where are Innovimmune Biotherapeutics's Headquarters?
Innovimmune Biotherapeutics's Headquarters are in Innovimmune Biotherapeutics ,New York,New York,United States
-
What is Innovimmune Biotherapeutics's phone number?
Innovimmune Biotherapeutics's phone number is +1 212-513-1786
-
What is Innovimmune Biotherapeutics's official website?
Innovimmune Biotherapeutics's official website is https://www.innovimmune.com
-
What is Innovimmune Biotherapeutics's Revenue?
Innovimmune Biotherapeutics's revenue is $1 - 10M
-
What is Innovimmune Biotherapeutics's NAICS code?
Innovimmune Biotherapeutics's NAICS code is 541713
-
How many employees are working in Innovimmune Biotherapeutics
Innovimmune Biotherapeutics has 6 employees
-
What is Innovimmune Biotherapeutics's Industry?
Innovimmune Biotherapeutics is in the industry of Biotechnology
-
Who is Innovimmune Biotherapeutics's CEO?
Innovimmune Biotherapeutics's CEO is Anderson Gaweco